Catalyst Wire Dossier Catalyst Wire Dossier

CD19/BCMA CAR-T therapy

· Nanjing Bioheng Biotech Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19/BCMA CAR-T therapy, covering 2026-02-02 to 2026-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases [EARLY_Phase 1]

See pricing